Low prevalence of hepatitis C virus infection in Greek diabetic patients
| Autor: | A. Sotiropoulos, E. Skliros, O. Apostolou, S. I. Pappas, V. Kotsini, T. A. Peppas |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Adult
Male medicine.medical_specialty Endocrinology Diabetes and Metabolism Hepatitis C virus medicine.disease_cause Endocrinology Risk Factors Internal medicine Immunopathology Diabetes mellitus Epidemiology Internal Medicine medicine Prevalence Humans Aged Hepatitis Greece business.industry Middle Aged medicine.disease Obesity Hepatitis C Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 Immunology Female Viral disease business Body mass index |
| Zdroj: | Diabetic medicine : a journal of the British Diabetic Association. 16(3) |
| ISSN: | 0742-3071 |
| Popis: | Summary Aim To assess the prevalence of hepatitis C virus (HCV) among Greek patients with Type 1 and 2 diabetes mellitus (DM), in view of the previous reports of high prevalence, particularly in patients with elevated aminotransferase. Methods We checked 423 diabetic patients (183 male, 240 female, mean age: 63 years) attending our unit, recording epidemiology data, diabetes history, treatment and classification. Patients were stratified by aminotransferase values (normal or elevated). HCV screening was performed using standard techniques. Statistical analysis was done by using the Student’s t-test for continuous variables and chi-square (χ2) for categorical data. Results Antibodies against HCV (anti-HCV) were detected in seven out of 423 diabetic patients (prevalence 1.65%). There was no correlation between HCV titre and diabetes type, duration, treatment, obesity (body mass index, BMI) or glycaemic control (HbA1c). The only correlation was elevated aminotransferase values (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text